RPG Life Sciences Limited — Earnings Release 2020

Jan 31, 2020

RPG LIFE SCIENCES LIMITED Unit No. 208-213, B Wing, Bezzola Complex, Sion-Trombay Road, Coombur, Mumbai 400071 , India Tel: +91-22·25292152•55 Fax: <-91 ·22-25297423

January 31 , 2020

To,

The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor Plot No. C1, 'G' Block, Sandra-Kurla Complex Sandra (Easl), Mumbai 400 051.

SSE Limited Corporate Relationship Department Floor 25, P.J. Towers Dalal Street Mumbai 400 001 .

Symbol: RPGLIFE

Scrip code: 532983

Dear Sirs,

Sub: Press Release· Financial Results

Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter ended December 31, 2019.

Kindly take the above on record.

Thanking you,

Yours faithfully, For RPG Life Sciences Limited

/' ~ *~ (0\t:..,,..,.J* ~ ie1fshiramoekar Head - Legal & Company Secretary

Encl: as above

RPG life Sciences Q3 Profit Before Tax.grows by 43.6%

MumbaJ, 31 January, 2020: RPG Life Sdences Limited has announced its finaricia,I results for the q1,1arter ended December 311\ 2019.

	YoY Net Revenue from Operatio!l_S_--+-	---YoV PBT from Operations '----
Q3 FY 20 Highlights	Rs 94.37 crores- up from Rs 90.97 crores	Rs 10.41 cro.res-upfrom Rs 7.25 crores
Nine Months FY 20H' hi. hrg ts 1_ __, __1g	----IRs 286.90 crores- up from Rs 261.36 er-ores---_ - -------	--------Rs 33.3lcrores- upfrom :Rs 12.93 crores-'----- ----

RPG Lif,e Sciences, enga.ged i.n the manufacturing and marketing of pharmaceutical products, posted its Q3 and N:ine months results. Q3 revenue is higher th an the corresponding quarter last year and PBT has registered a significant ju mp from Rs 7 .25 crores to Rs 10.41 crores. Overall, during nine months, Company's PBT stood at Rs 33.31 cro res versu:s Rs 12.93 crores over similar period last year and revenue increased by 10%.

''Q3 results are consistent with those of Ql and Q2 both on revenue and profit fronts , The turn-around performance is largely driven by the biggest contributing Domestfc business, which grew over 23%. Focus has been on prescription generation, pr!'.lduct portfolio rejuvenation, sales force effectiveness enhancement with strlct vigil on Sales hygiene." said Mr. Yugal Sikr~, Managing Director, RPG Life Sciences Ltd.

	EDITD~ margins improved from 13.3% to 15.8%1.
IQ3 FY20 Other Highlights(y-o-y}, _	2.Domestfc formufations saler. grew over 23% with all major brands--1 re,,.gistering healthy g'-ro_wt·h ~------
-----t------	---~-3__.Global ROW Sales grew by 26% ___ - ---------1
Nine months FY20 Other	--1. c--EDITDA margi11s improved from 10.5% to 16.4% -
Highlights (y·o·y}----~--	---·--Domestic formulations safos grew over 23.4% with all major brands2.--registering healthy double-digit growth -
---	---Global ROW Sales grew _ by 30% ___, _______________3. ---'--

RPG L!fi! 5dences Ltd (www.rpgl ife.sciences .co m):

RPG Life Sciences ltd,. part of RP.G Enterprises, is an integr<)ted pharmaceutical t::omp;:iny operating in the domestic an d iriternational markets in the branded f.orm ulattons, gjobal generic~ and synthetic APls space. The Company is a research-based pharmaceutical Company, producing a wide range of quality, afford.ible medicines. Its hrands are highly tr u.sted by healthcare profoss i onals and patle nts .

. RPG .Enterprises (www.rpg~ro up.com):

RPG Enterprises, established in 1979, is one of India's fastest growing business group.s with a t urnover of US$ 4 Bi ll.ion. The gro up 11.is diverse business interests in t he are.is of Infrastructure, Tyres, Pharma, ff and Specially as we ll as in emerging innovation-led technology businesses.

Media Contact: Su meet Chatterjee Senior Vice President- Group Communications sumeet@rpg.i ~ +91 98203406SO